Fundraising Fox
/People
Sign in

Yael Weiss

Founder

Founder at Mahzi Therapeutics

Evanston, Illinois, United States

FoundedMahzi Therapeutics

Find your path to Yael

Sign up to see every warm intro you have to Yael

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Yael. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Yael Weiss is the founder and Chief Executive Officer of Mahzi Therapeutics, which she established in 2021 to develop therapies for rare neurogenetic diseases in partnership with patient advocacy organizations. The company is currently dosing patients in a gene therapy trial for Pitt Hopkins syndrome, developed with the Pitt Hopkins Research Foundation. Weiss holds an MD from Hebrew University/Hadassah and a PhD from the Weizmann Institute, previously worked at Genzyme, Merck, and Ultragenyx, and is a 2022 Termeer Fellow and a member of the NIH Bespoke Gene Therapy Consortium and the ASGCT translational committee.

Founder at Mahzi Therapeutics

Intro paths

→

In turn, Yael can intro founders to Mahzi Therapeutics's investors below.

Mahzi Therapeutics's investors · 6

Droia VenturesLuxembourg · $540K checksHBM Healthcare InvestmentsZugHBM PartnersZug · $5M – $50M checksHealthCapStockholmMitsui Global InvestmentMenlo Park · $500K – $10M checksVenrockPalo Alto · $500K – $10M checks

Frequently asked questions

Who is Yael Weiss?
Yael Weiss is the founder and Chief Executive Officer of Mahzi Therapeutics, which she established in 2021 to develop therapies for rare neurogenetic diseases in partnership with patient advocacy organizations. The company is currently dosing patients in a gene therapy trial for Pitt Hopkins syndrome, developed with the Pitt Hopkins Research Foundation. Weiss holds an MD from Hebrew University/Hadassah and a PhD from the Weizmann Institute, previously worked at Genzyme, Merck, and Ultragenyx, and is a 2022 Termeer Fellow and a member of the NIH Bespoke Gene Therapy Consortium and the ASGCT translational committee.
Where does Yael Weiss work?
Yael Weiss is Founder of Mahzi Therapeutics.
What companies did Yael Weiss found?
Yael Weiss founded Mahzi Therapeutics.

Founder mafias

About this profile. Compiled from public sources — Mahzi Therapeutics's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights